Leadership Overview
Amgen has 8 executives leading key functions including finance, information technology, strategic planning, operations, and people management.
Driven by scientific discovery, Amgen is dedicated to advancing human health through innovative biotechnology, focusing on delivering life-changing therapies to patients worldwide.
Driven by scientific discovery, Amgen is dedicated to advancing human health through innovative biotechnology, focusing on delivering life-changing therapies to patients worldwide.
Leadership Roles at Amgen
Marianela Capelli - Chief Financial Officer (Argentina)
Marianela Capelli, the Chief Financial Officer (Argentina) at Amgen, directs financial operations within the Argentinian market. This leadership involves managing regional budgets, ensuring fiscal compliance with local regulations, and optimizing financial performance to support Amgen's global objectives. Capelli's oversight extends to financial reporting and strategic financial planning tailored to the specific economic landscape of Argentina. The role demands a deep understanding of international finance and local market dynamics to drive sustainable growth and profitability. By meticulously analyzing financial data, Marianela Capelli ensures robust financial health for Amgen's operations in the region, contributing to the company's overall economic strategy and market penetration.
Peter Griffith - Executive VP & Chief Financial Officer
Peter Griffith, the Executive VP & Chief Financial Officer at Amgen, directs the company's global financial strategy and operations. This senior leadership position encompasses managing all financial aspects, including accounting, treasury, financial planning and analysis, and investor relations, to support Amgen's mission of advancing human health. Griffith oversees the allocation of capital, drives financial discipline across the organization, and ensures robust financial reporting and compliance with global regulatory standards. The Chief Financial Officer plays a pivotal role in strategic decision-making, evaluating investment opportunities, and maintaining Amgen's strong financial position. Through astute financial management, Peter Griffith ensures the company has the resources necessary to fund groundbreaking research and development, ultimately enabling the delivery of innovative therapies to patients worldwide.

Scott Skellenger - Senior VP & Chief Information Officer
Scott Skellenger, the Senior VP & Chief Information Officer at Amgen, architects and executes the company's global information technology strategy. This critical role involves overseeing all aspects of Amgen's digital infrastructure, cybersecurity, and data management to support scientific research, drug development, and commercial operations. Skellenger drives technological innovation, ensuring that Amgen leverages cutting-edge solutions to enhance operational efficiency and accelerate therapeutic breakthroughs. The Chief Information Officer's responsibilities include managing IT budgets, leading global IT teams, and fostering a secure and reliable technology environment. By aligning IT initiatives with Amgen's core mission, Scott Skellenger ensures the company maintains its competitive edge in the rapidly evolving biotechnology landscape.
Katherine Rizos - Director, Strategic Planning & Operations & To The Chief of Staff & Chief Information Officer
Katherine Rizos, the Director, Strategic Planning & Operations & To The Chief of Staff & Chief Information Officer at Amgen, provides critical support for strategic initiatives and operational execution. This multifaceted role involves developing and implementing strategic plans that align with Amgen's long-term vision, while also managing key operational processes. Rizos works closely with the Chief of Staff and Chief Information Officer to ensure seamless integration of strategic objectives with technological advancements and operational workflows. The Director's focus includes enhancing organizational efficiency, driving cross-functional collaboration, and supporting the execution of high-priority projects. By bridging strategic planning with practical operations, Katherine Rizos contributes significantly to Amgen's ability to innovate and deliver life-changing medicines.
Valentina Guarino - Manager, Combination Product Operations (Chief People Officer)
Valentina Guarino, the Manager, Combination Product Operations (Chief People Officer) at Amgen, oversees critical aspects of combination product development and operations, with a focus on human capital management. This role integrates operational efficiency with people-centric strategies to ensure the successful delivery of Amgen's innovative therapeutic products. Guarino manages the operational workflows for combination products, ensuring adherence to quality and regulatory standards, while also championing initiatives that support employee development and engagement within the Chief People Officer function. The Manager's responsibilities include optimizing production processes and fostering a high-performing team environment. By aligning operational demands with people strategies, Valentina Guarino enhances Amgen's capacity to bring complex medical solutions to patients.
Raj Mistry - Engineer (Chief People Officer - MS & T)
Raj Mistry, the Engineer (Chief People Officer - MS & T) at Amgen, applies engineering principles to manage and enhance manufacturing science and technology (MS&T) operations, with a strategic focus on people management. This role involves optimizing engineering processes within MS&T to ensure the efficient and reliable production of Amgen's biopharmaceutical products. Mistry's responsibilities include leading engineering teams, implementing process improvements, and ensuring the technical integrity of manufacturing operations. As Chief People Officer for MS&T, Raj Mistry also focuses on talent development, team performance, and fostering a culture of innovation and excellence within the engineering and technical workforce. By integrating engineering expertise with people leadership, Mistry drives operational excellence and supports Amgen's commitment to delivering high-quality medicines.
Rene Marquina - Senior Engineer & Chief People Officer, Risk Engineering
Rene Marquina, the Senior Engineer & Chief People Officer, Risk Engineering at Amgen, leads critical risk engineering functions and oversees people management within this specialized domain. This dual role involves applying advanced engineering expertise to identify, assess, and mitigate operational and technical risks across Amgen's facilities and processes. Marquina directs engineering efforts to ensure the safety, reliability, and compliance of Amgen's manufacturing and research infrastructure. As Chief People Officer for Risk Engineering, Rene Marquina focuses on building and developing a skilled team, promoting best practices in risk management, and fostering a culture of proactive risk mitigation. By combining technical engineering acumen with strategic people leadership, Marquina strengthens Amgen's resilience and operational integrity.
Lisa Fries - Team Captain
Lisa Fries, the Team Captain at Amgen, leads a dedicated team focused on specific operational objectives. This role involves coordinating team efforts, ensuring project milestones are met, and fostering a collaborative environment conducive to achieving Amgen's scientific and business goals. Fries's leadership ensures efficient workflow management and effective task delegation within the team. The Team Captain's responsibilities include motivating team members, resolving operational challenges, and maintaining high standards of performance. By guiding the team's activities, Lisa Fries contributes to the successful execution of critical projects that support Amgen's broader mission of developing life-changing medicines.
Explore Leadership Teams in Manufacturing
Wockhardt Ltd. founded in 1999, is a global pharmaceutical and biotechnology company headquartered in Mumbai, India. The Company's businesses include the manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients, and vaccines.
Company Leadership NT
DM
NJ
PK
Founded in 1973 and headquartered in Bangalore, India, Micro Lab is a pharmaceutical manufacturer, wholesaler, and R&D company.
Company Leadership MH
RK
RB
PM
Dexcel Pharma is Israel’s largest privately owned pharmaceutical company, founded in 1968 and headquartered in Or Akiva. It develops, manufactures, and commercializes value‑added branded prescription drugs, generics, and OTC products—primarily oral solid dosage forms—supplying more than 85 products in over 175 dosage forms to markets including the U.S., U.K., Germany, Austria, and others through subsidiaries and distribution partners.
Company Leadership

EH

Tabuk Pharmaceuticals is a generic pharmaceutical company that delivers quality cost-effective prices in the regulated markets of the MENA region. The company provides to the major therapeutic areas of GI and diabetes, cardiovascular, musculoskeletal, respiratory, infection, and the central nervous system pharmaceuticals.
Company Leadership DB
IS

HR